Presentation of Research Abstract Confirming Clinical Efficacy of AITRICS-VC at the Luncheon Symposium

AITRICS (CEO Kwang joon Kim), a company specializing in artificial intelligence (AI) technology announced on the 29th that it shared key research results and the latest insights confirming the clinical efficacy of its patient deterioration prediction AI solution AITRICS-VC (VitalCare) at the Luncheon Symposium held during the '44th Korean Society of Critical Care Medicine Annual Conference (KSCCM·ACCC 2024)' on the 25th and 26th at the Grand InterContinental Seoul Parnas.

The symposium was attended by over 1,000 medical professionals from both domestic and international backgrounds. Professor Jeong Kyung-soo from Severance Hospital served as the chair, while Professor Lee Gi-byeong from Hallym University Chuncheon Sacred Heart Hospital presented on the topic of “Critical Prediction with AI.”

Professor Lee discussed the unmet demand for monitoring technologies that predict patient deterioration early in the hospital setting and introduced the key data from clinical research on the AI solution VitalCare, which is essential for proactive responses by healthcare professionals.

VitalCare analyzes a total of 19 data points, including 6 vital signs, 11 blood tests, consciousness status, and age, to predict the risk of occurrences such as sepsis, cardiac arrest, and mortality at an early stage.

During the symposium, Professor Lee stated, “In the case of sepsis, delays in diagnosis can occur due to the difficulty in identifying the causes for each patient case. Accurate diagnosis requires a comprehensive medical evaluation and interpretation of diagnostic test results. Our retrospective validation study, conducted on over 2,600 patients confirmed with sepsis out of approximately 45,000 adult patients in the general wards and ICUs of Chuncheon Sacred Heart Hospital, found that VitalCare can predict the occurrence of sepsis about 180 minutes before it actually occurs. This is expected to support timely decision-making by healthcare professionals and enhance treatment possibilities.”

He added, “VitalCare has shown significant data not only in retrospective studies but also in prospective studies. In a study conducted on around 4,700 patients at Keimyung University Dongsan Hospital, VitalCare demonstrated excellent sepsis prediction performance by predicting sepsis approximately 55 minutes earlier. This enables healthcare professionals to take swift action and increase the chances of successful treatment.”

Professor Jung Kyung Soo, who chaired the session, emphasized, “In most cases, abnormal signals are detected before a patient's condition deteriorates, but closely monitoring all patients is not easy. The need for systems that assist healthcare professionals in making immediate and appropriate clinical decisions and efficiently managing patients is becoming increasingly evident. Monitoring systems like VitalCare, which can predict emergency situations early, will improve patient outcomes and optimize the allocation of medical resources.”

CEO Kwang-jun Kim remarked, “It was a meaningful opportunity to share the significant results we have been researching at this annual conference of the Korean Society of Critical Care Medicine. Moving forward, AITRICS will continue to focus on research to provide high-quality medical services that help hospitalized patients return to their daily lives as quickly as possible, and we will strive to ensure that VitalCare is more widely adopted in healthcare settings to assist medical professionals.”